ArticleArthritis care & research2026
Serum Uric Acid Levels in Older Adults: Associations With Clinical Outcomes and Implications for Reference Intervals in Those Aged 70 Years and Over.
Article in Arthritis care & research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Associations between serum uric acid levels and risk of dementia in community-dwelling older adults.Alzheimer's & dementia (Amsterdam, Netherlands)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
objectiveReports have linked both high and low serum uric acid (SUA) levels to adverse health outcomes. This study aimed to establish a reference interval for SUA in older adults and assessed its association with clinically relevant outcomes in relatively healthy, community-dwelling individuals aged ≥70 years old.
methodsThe study used data from the ASPirin in Reducing Events in the Elderly (ASPREE) trial. In Australia, 11,878 ASPREE participants had baseline SUA measurements (median age 74 years old). The study sample (n = 11,446; 55% women) comprised individuals with baseline SUA measurements, excluding those on urate-lowering medication. The reference sample (n = 10,501; 55% women) was established after further exclusion of participants with impaired renal function, defined as an estimated glomerular filtration rate <45 mL/min/1.73m
resultsSUA reference intervals were 0.24 to 0.54 mmol/L for men and 0.19 to 0.48 mmol/L for women. After adjusting for potential confounders, no association was observed between SUA levels and all-cause mortality, disability-free survival, cardiovascular disease, major adverse cardiovascular events, cancer incidence and mortality, or dementia in either the study or reference samples. In women, however, low SUA levels were associated with an increased risk of fractures (hazard ratio 1.23; 95% confidence interval 1.04-1.46).
conclusionAlthough previous reports have linked abnormal SUA levels to adverse health outcomes, our findings show no associations within the reference range, except for an increased fracture risk among women with low SUA levels.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.